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In the past decade, isolation of multipotent cells from adiposetissue, termed adipose-derived stem cells (ASCs) or mesen-chymal stromal cells (MSCs), has triggered an increasing interestfor application in tissue engineering. 1 This type of stem cells
has shown the ability to differentiate toward different mesenchymal
cell lineages, such as osteogenic, chondrogenic, and adipogenic2,3 as
well as other cell types, including myocytes, and nerve cells.4,5 Unlike
MSCs harvested from bone marrow, ASCs are abundant and easy to
harvest, with no morbidity to the donor site, and because of their
osteogenic properties, they have been used in craniofacial surgery
animal models for calvarial defect reconstruction.
When referring to these cells, however, the term stem cell has
broadly applied to a specific cell population, harvested through li-
posuction of healthy donors and displaying specific properties, such
as adherence to plastic, fibroblastlike morphology, and the ability
to differentiate toward selected mesenchymal cell lineages. As de-
scribed, however, such cells share few characteristics with stem
cells from other tissues.
The work of our department during the last decade has shown
that stem cells from different organs grow under different culturing
conditions (in suspension), in serum-free conditions, and display a
phenotype characterized by round cells that do not adhere to plastic
supports and aggregate in clusters termed spheroids (multiclonal)
and spheres (monoclonal).6,7
Recently, our group is studying a cell fraction extracted from the
adipose tissue that resembles stem cells present in other tissues,
reopening the debate on the proper nomenclature of ASCs. Upon
isolation of these cells, we noted that they clearly displayed a
different phenotype from that of the traditional ASCs commonly
used in tissue engineering. This stem cell fraction could, indeed,
represent an upstream stage of the traditional ASCs before they enter
an early differentiation pathway and adhere to plastic solid supports.
Certainly, the manipulation of lipoaspirate and culture conditions in
which the stem cells grow plays a pivotal role in the maintenance
of the undifferentiated stage of the cells in suspension.
We hope, with our future studies, to put an end to the scientific
diatribe on whether true stem cells are present in the adipose tissue.
Our preliminary data suggest that the fibroblastlike adherent stromal
cells, considered as stem cells until now, may be downstream pre-
cursors of the true stem cells present in the adipose tissue. Indirectly,
the presence of such downstream precursors and the presence of
upstream spherelike cells represent indirect proof of the existence
of true stem cells in the adipose tissue.
Should these cells prove to be upstream progenitors of the tra-
ditional ASCs, their ability to grow in suspension as spheres (and
not as a monolayer) could provide new directions for tridimen-
sional tissue engineering, whereas their growth in serum-free cul-
tures could overcome the important limitations of autologous,
allogenic, and xenograft serum necessary for the growth of the ad-
herent ASCs. This could represent an initial step toward clinical
translation and routine application of such cells. Furthermore, their
use in serum-free conditions may find an indication in the immu-
nomodulation of vascularized composite allografts, providing ad-
vantages over the currently used infusion of MSCs harvested from
bone marrow.
The characterization and assessment of the biologic behavior, the
differentiation properties (multipotency versus pluripotency), and the
immunomodulatory properties of this cell niche, in comparison with
other stem cell types, are currently under investigation in our laboratory.
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